These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12446055)

  • 1. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.
    Beanlands RS; Ruddy TD; deKemp RA; Iwanochko RM; Coates G; Freeman M; Nahmias C; Hendry P; Burns RJ; Lamy A; Mickleborough L; Kostuk W; Fallen E; Nichol G;
    J Am Coll Cardiol; 2002 Nov; 40(10):1735-43. PubMed ID: 12446055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
    D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.
    Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L; Hendry P; Masters R; Ross H; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; Mielniczuk L; DaSilva JN; Garrard L; Wells GA; Beanlands RS;
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
    Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
    J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; de Boer J; Jager PL
    J Nucl Cardiol; 2006; 13(2):210-9. PubMed ID: 16580957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
    Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
    Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.
    Abraham A; Nichol G; Williams KA; Guo A; deKemp RA; Garrard L; Davies RA; Duchesne L; Haddad H; Chow B; DaSilva J; Beanlands RS;
    J Nucl Med; 2010 Apr; 51(4):567-74. PubMed ID: 20237039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.
    Marwick TH; Zuchowski C; Lauer MS; Secknus MA; Williams J; Lytle BW
    J Am Coll Cardiol; 1999 Mar; 33(3):750-8. PubMed ID: 10080477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction.
    Fath-Ordoubadi F; Pagano D; Marinho NV; Keogh BE; Bonser RS; Camici PG
    Am J Cardiol; 1998 Jul; 82(1):26-31. PubMed ID: 9671004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.
    Lund GK; Freyhoff J; Schwaiger M; Lübeck M; Lund CH; Buchert R; Sheehan FH; Meinertz T; Nienaber CA
    Cardiology; 2002; 98(4):202-9. PubMed ID: 12566650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism.
    Pasquet A; Lauer MS; Williams MJ; Secknus MA; Lytle B; Marwick TH
    Eur Heart J; 2000 Jan; 21(2):125-36. PubMed ID: 10637086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods.
    Beanlands R; Nichol G; Ruddy TD; deKemp RA; Hendry P; Humen D; Racine N; Ross H; Benard F; Coates G; Iwanochko RM; Fallen E; Wells G;
    Control Clin Trials; 2003 Dec; 24(6):776-94. PubMed ID: 14662282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
    Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
    J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model.
    Rizzello V; Schinkel AF; Bax JJ; Boersma E; Bountioukos M; Vourvouri EC; Krenning B; Agricola E; Roelandt JR; Poldermans D
    Am J Cardiol; 2003 Jun; 91(12):1406-9. PubMed ID: 12804724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
    Schöder H; Campisi R; Ohtake T; Hoh CK; Moon DH; Czernin J; Schelbert HR
    J Am Coll Cardiol; 1999 Apr; 33(5):1328-37. PubMed ID: 10193735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.